Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Sink, R.; Sosic, I.; Zivec, M.; Fernandez-Menendez, R.; Turk, S.; Pajk, S.; Alvarez-Gomez, D.; Lopez-Roman, E.M.; Gonzales-Cortez, C.; Rullas-Triconado, J.; Angulo-Barturen, I.; Barros, D.; Ballell-Pages, L.; Young, R.J.; Encinas, L.; Gobec, S.
    Design, synthesis, and evaluation of new thiadiazole-based direct inhibitors of enoyl acyl carrier protein reductase (InhA) for the treatment of tuberculosis (2015), J. Med. Chem., 58, 613-624.
    View publication on PubMed

Inhibitors

EC Number Inhibitors Comment Organism Structure
1.3.1.9 1-(4-methyl-1,3-thiazol-2-yl)-1-(5-[[6-(morpholin-4-yl)pyridin-2-yl]amino]-1,3,4-thiadiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-(4-methyl-1,3-thiazol-2-yl)-1-(5-[[6-(piperidin-1-yl)pyridin-2-yl]amino]-1,3,4-thiadiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-(4-methyl-1,3-thiazol-2-yl)-1-(5-[[6-(trifluoromethyl)pyridin-2-yl]amino]-1,3,4-thiadiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-(4-methyl-1,3-thiazol-2-yl)-1-[5-[(1-methyl-1H-1,2,3-triazol-4-yl)amino]-1,3,4-thiadiazol-2-yl]ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-(4-methyl-1,3-thiazol-2-yl)-1-[5-[(pyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-(4-methyl-1,3-thiazol-2-yl)-1-[5-[(pyrimidin-2-yl)amino]-1,3,4-thiadiazol-2-yl]ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-(5-[[5-bromo-6-(trifluoromethyl)pyridin-2-yl]amino]-1,3,4-thiadiazol-2-yl)-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-[5-(3-bromo-4-fluoroanilino)-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-[5-[(1-methyl-1H-pyrazol-3-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-[5-[(1-methyl-1H-pyrazol-4-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-[5-[(2-methoxypyridin-4-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-[5-[(2-methylpyridin-3-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-[5-[(5-bromo-6-methylpyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-[5-[(5-bromopyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-[5-[(5-fluoropyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-[5-[(5-methylpyridin-3-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-[5-[(6-bromopyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-[5-[(6-cyclopropylpyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-[5-[(6-fluoropyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-[5-[(6-methoxypyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-[5-[(6-methylpyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 1-[5-[(6-methylpyridin-3-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
-
Mycobacterium tuberculosis
1.3.1.9 4-methylthiazole
-
Mycobacterium tuberculosis
1.3.1.9 6-([5-[1-hydroxy-1-(4-methyl-1,3-thiazol-2-yl)ethyl]-1,3,4-thiadiazol-2-yl]amino)pyridin-2-ol
-
Mycobacterium tuberculosis
1.3.1.9 isoniazid
-
Mycobacterium tuberculosis
1.3.1.9 triclosan
-
Mycobacterium tuberculosis

Natural Substrates/ Products (Substrates)

EC Number Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
1.3.1.9 an acyl-[acyl-carrier protein] + NAD+ Mycobacterium tuberculosis
-
a trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH + H+
-
r
1.3.1.9 an acyl-[acyl-carrier protein] + NAD+ Mycobacterium tuberculosis H37Rv
-
a trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH + H+
-
r

Organism

EC Number Organism UniProt Comment Textmining
1.3.1.9 Mycobacterium tuberculosis
-
-
-
1.3.1.9 Mycobacterium tuberculosis H37Rv
-
-
-

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
1.3.1.9 2-trans-dodecenoyl-CoA + NADH + H+
-
Mycobacterium tuberculosis dodecanoyl-CoA + NAD+
-
?
1.3.1.9 2-trans-dodecenoyl-CoA + NADH + H+
-
Mycobacterium tuberculosis H37Rv dodecanoyl-CoA + NAD+
-
?
1.3.1.9 an acyl-[acyl-carrier protein] + NAD+
-
Mycobacterium tuberculosis a trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH + H+
-
r
1.3.1.9 an acyl-[acyl-carrier protein] + NAD+
-
Mycobacterium tuberculosis H37Rv a trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH + H+
-
r

Synonyms

EC Number Synonyms Comment Organism
1.3.1.9 enoyl acyl carrier protein reductase
-
Mycobacterium tuberculosis
1.3.1.9 InhA
-
Mycobacterium tuberculosis

Cofactor

EC Number Cofactor Comment Organism Structure
1.3.1.9 NAD+
-
Mycobacterium tuberculosis
1.3.1.9 NADH
-
Mycobacterium tuberculosis

IC50 Value

EC Number IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
1.3.1.9 0.000013
-
at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-[5-[(6-bromopyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
1.3.1.9 0.000018
-
at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-(4-methyl-1,3-thiazol-2-yl)-1-(5-[[6-(trifluoromethyl)pyridin-2-yl]amino]-1,3,4-thiadiazol-2-yl)ethan-1-ol
1.3.1.9 0.000046
-
at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-(5-[[5-bromo-6-(trifluoromethyl)pyridin-2-yl]amino]-1,3,4-thiadiazol-2-yl)-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
1.3.1.9 0.000077
-
at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-[5-[(6-cyclopropylpyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
1.3.1.9 0.000179
-
at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-[5-[(5-bromo-6-methylpyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
1.3.1.9 0.000197
-
at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-[5-[(5-bromopyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
1.3.1.9 0.00026
-
at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-[5-[(6-methylpyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
1.3.1.9 0.000264
-
at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-[5-[(6-methoxypyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
1.3.1.9 0.000299
-
at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-(4-methyl-1,3-thiazol-2-yl)-1-(5-[[6-(piperidin-1-yl)pyridin-2-yl]amino]-1,3,4-thiadiazol-2-yl)ethan-1-ol
1.3.1.9 0.000363
-
at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-[5-[(5-fluoropyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
1.3.1.9 0.000386
-
at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-(4-methyl-1,3-thiazol-2-yl)-1-[5-[(pyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]ethan-1-ol
1.3.1.9 0.000551
-
at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-[5-[(6-fluoropyridin-2-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
1.3.1.9 0.000741
-
at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-[5-[(2-methoxypyridin-4-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
1.3.1.9 0.000894
-
at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-[5-[(1-methyl-1H-pyrazol-3-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
1.3.1.9 0.001
-
IC 50 above 0.001 mM, at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-(4-methyl-1,3-thiazol-2-yl)-1-(5-[[6-(morpholin-4-yl)pyridin-2-yl]amino]-1,3,4-thiadiazol-2-yl)ethan-1-ol
1.3.1.9 0.001
-
IC 50 above 0.001 mM, at 37°C, pH not specified in the publication Mycobacterium tuberculosis 6-([5-[1-hydroxy-1-(4-methyl-1,3-thiazol-2-yl)ethyl]-1,3,4-thiadiazol-2-yl]amino)pyridin-2-ol
1.3.1.9 0.001
-
IC 50 above 0.001 mM, at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-(4-methyl-1,3-thiazol-2-yl)-1-[5-[(pyrimidin-2-yl)amino]-1,3,4-thiadiazol-2-yl]ethan-1-ol
1.3.1.9 0.001
-
IC 50 above 0.001 mM, at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-[5-[(5-methylpyridin-3-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
1.3.1.9 0.001
-
IC 50 above 0.001 mM, at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-[5-[(6-methylpyridin-3-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
1.3.1.9 0.001
-
IC 50 above 0.001 mM, at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-[5-[(2-methylpyridin-3-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
1.3.1.9 0.001
-
IC 50 above 0.001 mM, at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-[5-(3-bromo-4-fluoroanilino)-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
1.3.1.9 0.001
-
IC 50 above 0.001 mM, at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-[5-[(1-methyl-1H-pyrazol-4-yl)amino]-1,3,4-thiadiazol-2-yl]-1-(4-methyl-1,3-thiazol-2-yl)ethan-1-ol
1.3.1.9 0.001
-
IC 50 above 0.001 mM, at 37°C, pH not specified in the publication Mycobacterium tuberculosis 1-(4-methyl-1,3-thiazol-2-yl)-1-[5-[(1-methyl-1H-1,2,3-triazol-4-yl)amino]-1,3,4-thiadiazol-2-yl]ethan-1-ol
1.3.1.9 0.004
-
at 37°C, pH not specified in the publication Mycobacterium tuberculosis 4-methylthiazole